2seventy bio Inc. (TSVT)
2seventy bio Statistics
Share Statistics
2seventy bio has 52.34M shares outstanding. The number of shares has increased by 1.81% in one year.
| Shares Outstanding | 52.34M |
| Shares Change (YoY) | 1.81% |
| Shares Change (QoQ) | 1.45% |
| Owned by Institutions (%) | 87.93% |
| Shares Floating | 47.46M |
| Failed to Deliver (FTD) Shares | 18 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 5.08M, so 9.84% of the outstanding shares have been sold short.
| Short Interest | 5.08M |
| Short % of Shares Out | 9.84% |
| Short % of Float | 10.49% |
| Short Ratio (days to cover) | 11.5 |
Valuation Ratios
The PE ratio is -2.68 and the forward PE ratio is -2.45. 2seventy bio's PEG ratio is 0.04.
| PE Ratio | -2.68 |
| Forward PE | -2.45 |
| PS Ratio | 4.05 |
| Forward PS | 2.9 |
| PB Ratio | 0.73 |
| P/FCF Ratio | -1.79 |
| PEG Ratio | 0.04 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for 2seventy bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.67, with a Debt / Equity ratio of 1.16.
| Current Ratio | 4.67 |
| Quick Ratio | 4.67 |
| Debt / Equity | 1.16 |
| Debt / EBITDA | -2.48 |
| Debt / FCF | -2.84 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $582.49K |
| Profits Per Employee | $-880.72K |
| Employee Count | 65 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -13.32% in the last 52 weeks. The beta is 1.05, so 2seventy bio's price volatility has been higher than the market average.
| Beta | 1.05 |
| 52-Week Price Change | -13.32% |
| 50-Day Moving Average | 3.58 |
| 200-Day Moving Average | 3.97 |
| Relative Strength Index (RSI) | 74.16 |
| Average Volume (20 Days) | 1.13M |
Income Statement
In the last 12 months, 2seventy bio had revenue of 37.86M and earned -57.25M in profits. Earnings per share was -1.1.
| Revenue | 37.86M |
| Gross Profit | 37.86M |
| Operating Income | -115.43M |
| Net Income | -57.25M |
| EBITDA | -98.45M |
| EBIT | -105.54M |
| Earnings Per Share (EPS) | -1.1 |
Balance Sheet
The company has 71.24M in cash and 243.72M in debt, giving a net cash position of -172.47M.
| Cash & Cash Equivalents | 71.24M |
| Total Debt | 243.72M |
| Net Cash | -172.47M |
| Retained Earnings | -568.46M |
| Total Assets | 479.51M |
| Working Capital | 147.16M |
Cash Flow
In the last 12 months, operating cash flow was -85M and capital expenditures -707K, giving a free cash flow of -85.7M.
| Operating Cash Flow | -85M |
| Capital Expenditures | -707K |
| Free Cash Flow | -85.7M |
| FCF Per Share | -1.64 |
Margins
Gross margin is 100%, with operating and profit margins of -304.87% and -151.2%.
| Gross Margin | 100% |
| Operating Margin | -304.87% |
| Pretax Margin | -151.2% |
| Profit Margin | -151.2% |
| EBITDA Margin | -260.01% |
| EBIT Margin | -304.87% |
| FCF Margin | -226.36% |
Dividends & Yields
TSVT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for TSVT is $5, which is 2.5% higher than the current price. The consensus rating is "Hold".
| Price Target | $5 |
| Price Target Difference | 2.5% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
Scores
| Altman Z-Score | -1.36 |
| Piotroski F-Score | 2 |